Efficacy and Safety of Dysport® (AbobotulinumtoxinA) in Pediatric Lower Limb Spasticity
People with Pediatric Lower Limb Spasticity are being asked to participate in a research study being conducted by Montefiore Medical Center.
You may be eligible to participate in this study if your child:
- Is a female or male aged 2 to 17 years old
- Has primary diagnosis of PLL spasticity and either previously untreated with abotulinum neurotoxin (BoNT) or previously treated with BoNT
You may not participate in this study if your child:
- Has known resistance to any BoNT or experienced serious safety issues with previous use of BoNT
- Has had previous treatment with aminoglycoside antibiotics within the last 30 days
- Has a current need for surgery in the lower limb
- Is pregnant and/or a lactating female
Contact Information
Beendu Pujar, Study Coordinator
111 E. 210th Street
Bronx, New York 10467
Phone: (718) 920-4321
Email: bpujar@montefiore.org